Literature DB >> 33251505

COVID-19-Associated Acute Kidney Injury.

Malvinder S Parmar1.   

Abstract

Entities:  

Year:  2020        PMID: 33251505      PMCID: PMC7680016          DOI: 10.1016/j.xkme.2020.09.006

Source DB:  PubMed          Journal:  Kidney Med        ISSN: 2590-0595


× No keyword cloud information.
To the Editor: In their case series of acute kidney injury (AKI) associated with coronavirus disease 2019 (COVID-19), Patel et al proposed that a hypercatabolic state with muscle breakdown was the cause of AKI as they presented 3 cases that typify hypercatabolic state, with rapid increase in serum urea nitrogen levels, hyperuricemia, and hyperphosphatemia. However, in all 3 cases, the urea-creatinine ratio (UCR) was unchanged and was not elevated, as is observed in a hypercatabolic state. Serum urea nitrogen and creatinine levels (UCR initial/peak: case 1, 17.5/16.2; case 2, 12/13; case 3, 9.7/13) in all 3 cases were essentially unchanged and were not in keeping with a true hypercatabolic state. In addition, the near-normal creatine kinase levels do not support significant muscle breakdown unless these patients had pre-existing cachexia. The hyperuricemia and hyperphosphatemia could very well be the effects of AKI rather than initiating factors; however, their role in perpetuation of AKI can not be excluded. The rapid decrease in serum albumin level is more consistent with a capillary leak syndrome, as seen in severe sepsis-systemic inflammatory response syndrome that I agree results from the various inflammatory cytokines (interleukin 6, tumor necrosis factor, etc). I agree with the authors that better understanding of the factors associated with COVID-19–associated AKI and the role of cytokines is important.
  2 in total

1.  Elevated urea-to-creatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major trauma.

Authors:  Ryan W Haines; Parjam Zolfaghari; Yize Wan; Rupert M Pearse; Zudin Puthucheary; John R Prowle
Journal:  Intensive Care Med       Date:  2019-09-17       Impact factor: 17.440

  2 in total
  1 in total

1.  In Reply to 'COVID-19-Associated Kidney Injury'.

Authors:  Niralee Patel; Joshua L Rein; Luis Sanchez-Russo; Jonathan Winston; Jaime Uribarri
Journal:  Kidney Med       Date:  2020-11-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.